EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

CRISPR/Cas9-Mediated Genome Editing of T4 Bacteriophage for High-Throughput Antimicrobial Susceptibility Testing

Yawen He iD, Juhong Chen iD

Analytical Chemistry · 2024

DOI: 10.1021/acs.analchem.4c05177 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Chemistry, 2024. Verfasst von Yawen He und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Systems Engineering, Virginia Tech, Blacksburg, Virginia 24061, United States. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Gene Editing, Bacteriophage T4, Escherichia coli. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, National Institute of Food and Agriculture, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The accurate and effective determination of antimicrobial resistance is essential to limiting the spread of infectious diseases and ensuring human health. Herein, a simple, accurate, and high-throughput phage-based colorimetric sensing strategy was developed for antimicrobial susceptibility testing (AST). Taking advantage of the CRISPR/Cas9 system, the genome of the T4 phage was modularly engineered to carry lacZ-α (lacZa), a marker gene encoding the α-fragment of β-galactosidase (β-gal). T4lacZa phages were identified by blue-white selection and then used for a biosensing application. In this strategy, the bacterial solution is exposed to the T4lacZa phage, causing target bacteria to overexpress β-gal. Upon the addition of a colorimetric substrate, the β-gal initiates an enzymatic reaction, resulting in a solution color change from yellow to red. This sensing strategy offers a visual way to monitor bacterial growth in the presence of antibiotics, enabling the determination of bacterial antimicrobial susceptibility. As a proof of concept, our developed sensing strategy was successfully applied to identify 9 different multidrug-resistant Escherichia coli (E. coli) in urine samples with 100% specificity. Compared with conventional disk diffusion susceptibility tests, the engineered phage-based sensing strategy can shorten the detection time by at least half without losing detection sensitivity, providing an alternative high-throughput method for AST in clinical diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsGene EditingBacteriophage T4Escherichia coliMicrobial Sensitivity TestsAnti-Bacterial AgentsHumansColorimetryHigh-Throughput Screening Assaysbeta-Galactosidase

Substanzen

Anti-Bacterial Agentsbeta-Galactosidase

Autor:innen und Institutionen

  • Department of Biological Systems Engineering, Virginia Tech, Blacksburg, Virginia 24061, United States.
  • Department of Bioengineering, University of California, Riverside, California 92521, United States.

ORCID-Profile: Yawen He, Juhong Chen

Förderung

  • NIGMS NIH HHS
  • National Institute of Food and Agriculture
  • National Institute of General Medical Sciences

Zitieren

APA

He, Y., & Chen, J. (2024). CRISPR/Cas9-Mediated Genome Editing of T4 Bacteriophage for High-Throughput Antimicrobial Susceptibility Testing. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.4c05177

Vancouver

He Y, Chen J. CRISPR/Cas9-Mediated Genome Editing of T4 Bacteriophage for High-Throughput Antimicrobial Susceptibility Testing. Analytical Chemistry. 2024. doi:10.1021/acs.analchem.4c05177

BibTeX
@article{He2024,
  author = {He, Yawen and Chen, Juhong},
  title = {CRISPR/Cas9-Mediated Genome Editing of T4 Bacteriophage for High-Throughput Antimicrobial Susceptibility Testing},
  journal = {Analytical Chemistry},
  year = {2024},
  doi = {10.1021/acs.analchem.4c05177}
}
Kostenlos starten →